InsidersTradesSigma
차바이오텍: management transactions · South Korea · DART (FSS)
DART:company-ba0041KR·DART (FSS)Mcap 1093.7Bn€Healthcare
Browse the full insider trade history of 차바이오텍, a listed issuer based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Healthcare sector, 차바이오텍 has published 5 insider filings. Market capitalisation: €1,093.7bn. The latest transaction was reported on 1 April 2026 — Sale. Among the most active insiders: 차광렬. Every trade is accessible without an account.
5
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
€846,999
3 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
14310.00 €
Analyst consensus
Income statement
Revenue1268.25 Bn€
Gross profit363.75 Bn€29% margin
Net income−109.88 Bn€-8.7% margin
Valuation
Beta0.68
Balance sheet & cash
Market cap1093.66 Bn€
Total debt905.43 Bn€
Free Cash Flow−224.59 Bn€
Debt / Equity108%
Profitability & ownership
ROE-18.6%
ROA-1.5%
% insiders24.8%
% institutions7.2%
Last declaration on 1 April 2026
Declarations5 total
Executives●Other0DART
DART:20260317000854·details not loaded
Executives●Other0DART
DART:20260316001633·details not loaded
5 of 5 declarations